ZT-01 aims to restore glucagon counterregulation during hypoglycaemia. But type 1 diabetes already produces glucagon at the wrong time — and Zucara’s own human data show SSTR2 blockade raises glucagon, glucose and insulin requirements during euglycaemia. What will the trials tell us about its longer term effects?
Are two hormones and an algorithm enough? Or is diabetes far more complex than that?
Everyone with type 1 is taught that the big orange plastic box that we’re supposed to keep in the fridge is for emergencies only and […]
Whilst we are on the subject of novel diabetes treatments, I recently came across Hepatocyte Directed Vesicle Insulin from Diasome, and this one is a […]
Following discussions on the diabetes.co.uk forum recently, I decided that it was worth re-addressing the issue of Glucagon in the Type 1 Metabolic cycle. But […]
Eggs, for many T1s, require almost as much insulin as carbohydrate. Yet eggs contain no noticeable carbs. What they do have is loads of protein […]
Why Harrumph?. Sometimes they feel like an inordinate waste of time. Take mine today as an example. It was what I’d describe as frustrating and […]
Since getting my hands on my Freestyle Libre, I’ve been able to gain a whole new insight into how my diabetes works, and how my […]
Copyright © 2026 | WordPress Theme by MH Themes